Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN
Article in American Heart Journal (May 2024)
The most recent citing publications are shown below. View all 563 publications that cite this research output on Dimensions.
Article in American Heart Journal (May 2024)
Article in Social Science & Medicine (May 2024)
Article in Current Atherosclerosis Reports (April 2024)